Ensuring the Involvement of Children in the Evaluation of New Tuberculosis Treatment Regimens
Authors:
- William J BurmanWBWilliam J Burman
- Mark F CottonMCMark F Cotton
- Diana M GibbDGDiana M Gibb
- A. Sarah WalkerAWA. Sarah Walker
- Andrew A VernonAVAndrew A Vernon
- Peter R DonaldPDPeter R Donald
Open Access
- 19 August 2008
- journal article
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 5 (8) , e176
Abstract
William Burman and colleagues review the barriers to involving children in studies of new tuberculosis treatments and recommend strategies for overcoming these barriers.Keywords
This publication has 37 references indexed in Scilit:
- Global epidemiology of childhood tuberculosis.2004
- The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era.2004
- Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and IrelandBMJ, 2003
- Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Community-Based Therapy for Multidrug-Resistant Tuberculosis in Lima, PeruNew England Journal of Medicine, 2003
- Effect of Combination Therapy Including Protease Inhibitors on Mortality among Children and Adolescents Infected with HIV-1New England Journal of Medicine, 2001
- The Outcome of Tuberculosis Treatment at a Rural Hospital in Southern EthiopiaTropical Doctor, 2001
- Antimycobacterial pyrroles: synthesis, anti- Mycobacterium tuberculosis activity and QSAR studiesBioorganic & Medicinal Chemistry, 2000
- Sputum induction for the diagnosis of pulmonary tuberculosis in infants and young children in an urban setting in South AfricaArchives of Disease in Childhood, 2000
- Factors predicting non-completion of tuberculosis treatment among HIV-infected patients in Barcelona (1987-1996).2000